Alyeska Investment Group
SHAC

Alyeska Investment Group’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Alyeska Investment Group’s Portfolio SHAC Stock Details SHAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250,000
Closed -$2.46M – 651
2022
Q2 		$2.46M Hold
250,000
– – 0.03% 386
2022
Q1 		$2.44M Hold
250,000
– – 0.03% 399
2021
Q4 		$2.45M Hold
250,000
– – 0.03% 415
2021
Q3 		$2.43M Hold
250,000
– – 0.03% 477
2021
Q2 		$2.42M Buy
+250,000
New +$2.43M 0.03% 487

Other funds holding SHAC

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Alyeska Investment Group's SHAC Position: Q3 2022 in Review

Alyeska Investment Group sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q3 2022, closing a stake of 250,000 shares — an estimated $2.46M sold.

Alyeska Investment Group first reported a position in SHAC in Q2 2021 and held it in 5 quarters. The position peaked at $2.46M in Q2 2022. 68 funds tracked by Wall St. Rank hold SHAC as of Q3 2022.

  • Alyeska Investment Group reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 250,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q3 2022, an estimated $2.46M.
  • Alyeska Investment Group first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 5 quarters.
  • Alyeska Investment Group's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $2.46M in Q2 2022.
  • 68 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.